Botanix Pharmaceuticals Ltd (ASX: BOT) — Healthcare · Share Price, Chart & Market Data
About: Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1801 for treating staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 for the treatment of papulopustular rosacea; and BTX 1204A for treating atopic dermatitis. The company was incorporated in 1984 and is based in West Perth, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.03 (-3.03%)
BOTBotanix Pharmaceuticals Ltd
Loading watchlist status…
Trade BOT now
Botanix Pharmaceuticals Ltd share price
BOT price activity
Last Price
Change (24hr)
AUD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 8:49 am GMT+0
BOT price performance
-13.514%
5D
-20%
1M
-76.296%
YTD
-92.381%
1Y
BOT price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
ASX rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 8:49 am GMT+0
BOT details
BOT Market Signals